Top segments and regional performance

Last year, the company generated 144.28 M USD, the most of which — 144.28 M USD — came from its top-performing segment, Therapeutic Innovations, compared to 127.04 M USD the previous year. The greatest contribution came from United States, which accounted for 144.28 M USD last year, with 127.04 M USD the year before.